APA (7th ed.) Citation

SJ, S., T, F., MJ, R., R, K., S, L., S, L., . . . L, M. (2018). One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial. JAMA cardiology, 3(10), 968. https://doi.org/10.1001/jamacardio.2018.2936

Chicago Style (17th ed.) Citation

SJ, Shah, et al. "One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial." JAMA Cardiology 3, no. 10 (2018): 968. https://doi.org/10.1001/jamacardio.2018.2936.

MLA (9th ed.) Citation

SJ, Shah, et al. "One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial." JAMA Cardiology, vol. 3, no. 10, 2018, p. 968, https://doi.org/10.1001/jamacardio.2018.2936.